ATLANTA, Feb. 15, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that President and CEO Rick Eiswirth will present at the Microcap Rodeo Winter Wonderland Conference, which will be held from February 16-19, 2021.
The presentation will be webcast live on February 16, 2021 at 1:00PM ET and then available for on-demand listening. The Company will be available for one-on-one meetings on February 18 and 19, 2021. For those interested in viewing Mr. Eiswirth’s presentation, which includes live Q&A, it can be accessed here.
About Alimera Sciences, Inc.
Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations. For more information, please visit www.alimerasciences.com.
| For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com |
For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
Experienced Healthcare Executive Brings Extensive Financial and Operational Expertise to Cutera Board of DirectorsBRISBANE, Calif.--(BUSINESS…
Roland Rott, the current president and CEO of Ultrasound, will lead Imaging, replacing Jan Makela…
NEW YORK, June 10, 2024 /PRNewswire/ -- The global glass lens market size is estimated to grow…
NEW YORK, June 10, 2024 /PRNewswire/ -- The global digital pathology market size is estimated to…
Company appoints Pearl Barnett as Chief Operating Officer; Megan Owen becomes Chief Compliance Officer STURGIS,…
MORRISVILLE, N.C., June 10, 2024 /PRNewswire/ -- IEM International, Inc., a global leader in emergency…